Methods for inhibiting viral replication in vivo
US7204980B2 · kind B2 · utility
23Cited by
9References
41Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 29, 2003 |
| Grant date | Apr 17, 2007 |
| Priority date | — |
| Expiry date | Sep 29, 2023 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to methods of modulating viral replication in vivo comprising administering to an individual a therapeutically or prophylactically effective amount of a composition comprising arginine deiminase modified with polyethylene glycol, to methods of concurrently modulating viral replication and treating cancer, and to methods of modulating nitric oxide levels in a patient, among others.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.